Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 6 Nov 2026

ZYDUSLIFE, full dossier

Zydus Lifesciences posted a 26.6 per cent decline in consolidated net profit to ₹925.5 crore in the September quarter.

6 publishers have reported this development. Each act of reporting is below, cited.

The record

Zydus Lifesciences posted a 26.6 per cent decline in consolidated net profit to ₹925.5 crore in the September quarter.

Net profit of Zydus Lifesciences declined 26.47% to Rs 925.50 crore in the quarter ended September 2026 as against Rs 1258.60 crore during the previous quarter ended September 2025.

Zydus Lifesciences reported a 29% year-on-year increase in revenue from operations to Rs 7,909 crore for the September quarter, but net profit declined 27% to Rs 925 crore due to a rise in expenses.

indiatimes.com4 Nov 2026

Zydus Lifesciences reported a 27% drop in Q2 profit.

Zydus Lifesciences reported a 29.2% year-on-year increase in revenue to ₹7,910 crore in Q2 FY27, compared with ₹6,123 crore in the corresponding quarter last year.

cnbctv18.com4 Nov 2026

Zydus Lifesciences' consolidated net profit declined 26.6 per cent year-on-year to Rs 925.5 crore in the July-September quarter.

zeebiz.com4 Nov 2026

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.